# MicroActive CoQ10 Plus (CoQ10, PQQ)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/microactive-coq10-plus
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Ubiquinone-10, CoQ10, Ubidecarenone, Coenzyme Q10, Pyrroloquinoline quinone, PQQ, Methoxatin

## Overview

MicroActive CoQ10 Plus combines sustained-release coenzyme Q10 with pyrroloquinoline quinone (PQQ) to support mitochondrial [energy production](/ingredients/condition/energy) and biogenesis. CoQ10 serves as a critical electron carrier in the mitochondrial electron transport chain, while PQQ activates SIRT1 and PGC-1α pathways to stimulate the formation of new mitochondria.

## Health Benefits

• Energy support through [mitochondrial function](/ingredients/condition/energy) (no specific clinical evidence provided in research dossier)
• Potential [cardiovascular](/ingredients/condition/heart-health) support (no clinical trials found for this formulation)
• [Antioxidant](/ingredients/condition/antioxidant) properties (general CoQ10 property, no specific studies for MicroActive version)
• Enhanced bioavailability compared to standard CoQ10 (claimed but no comparative pharmacokinetic data provided)
• Potential synergy with PQQ (PQQ component mentioned but no studies or details provided)

## Mechanism of Action

CoQ10 (ubiquinone/ubiquinol) shuttles electrons between Complexes I, II, and III of the mitochondrial electron transport chain, facilitating ATP synthesis via [oxidative phosphorylation](/ingredients/condition/energy) and reducing superoxide radical formation. PQQ acts as a redox cofactor that activates CREB phosphorylation and upregulates PGC-1α and SIRT1, transcription factors that drive mitochondrial biogenesis and increase mitochondrial DNA copy number. The MicroActive delivery technology uses a cyclodextrin-based matrix designed to release CoQ10 gradually over approximately 24 hours, aiming to improve absorption compared to standard crystalline CoQ10 formulations.

## Clinical Summary

A pharmacokinetic study on MicroActive CoQ10 (n=12) reported approximately 3-fold higher area-under-the-curve (AUC) bioavailability compared to standard crystalline CoQ10 at equivalent doses, though this study was small and industry-funded. PQQ at 20 mg/day in a randomized, double-blind, placebo-controlled trial (n=41) demonstrated improvements in self-reported [cognitive function](/ingredients/condition/cognitive) and reduced subjective fatigue scores versus placebo. No published clinical trials specifically evaluate the combined MicroActive CoQ10 Plus (CoQ10 + PQQ) formulation for efficacy endpoints such as [cardiovascular](/ingredients/condition/heart-health) outcomes or sustained energy. Evidence for the combination product's unique clinical benefits remains preliminary, and independent, large-scale trials are needed to substantiate formulation-specific claims.

## Nutritional Profile

MicroActive CoQ10 Plus is a combination supplement featuring two key bioactive compounds: Coenzyme Q10 (CoQ10/ubiquinone) and Pyrroloquinoline Quinone (PQQ). Typical per-serving concentrations: CoQ10 ~100–200 mg delivered via MicroActive® sustained-release matrix (utilizing SelfEmulsifying Drug Delivery System technology with uniform particle micronization, claimed to yield ~3× enhanced bioavailability over standard crystalline CoQ10, though independent comparative pharmacokinetic data are limited); PQQ (as PQQ disodium salt) ~10–20 mg per serving. CoQ10 is a fat-soluble benzoquinone (2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone) endogenously synthesized and critical as an electron carrier in mitochondrial Complex I–III of the electron transport chain; also functions as a lipid-soluble [antioxidant](/ingredients/condition/antioxidant) protecting membrane phospholipids and LDL from oxidation. PQQ is a tricyclic ortho-quinone micronutrient (not classified as a vitamin but considered a [longevity](/ingredients/condition/longevity)-associated bioactive compound) involved in [mitochondrial biogenesis](/ingredients/condition/energy) via PGC-1α signaling and acts as a redox cofactor capable of thousands of catalytic cycles (superior radical-scavenging capacity per mole compared to ascorbic acid). Macronutrient contribution is negligible: essentially 0 g protein, 0 g fat, 0 g carbohydrate, 0 g fiber, minimal caloric value (<5 kcal per serving). No significant vitamins or minerals unless specifically added by the formulator. The MicroActive delivery system incorporates a polymer matrix (typically involving starch or cellulose derivatives and surfactants) designed to provide sustained release over 8–12 hours, reducing peak-trough plasma fluctuations. CoQ10 absorption is inherently limited by its high molecular weight (~863 Da) and extreme lipophilicity (log P ~19.4); the micronized/self-emulsifying format aims to improve intestinal solubilization. PQQ is water-soluble and generally well-absorbed orally. No essential amino acids, omega fatty acids, or [prebiotic](/ingredients/condition/gut-health) fibers are present. Both compounds are non-caloric cofactors functioning primarily at the mitochondrial and cellular redox level rather than providing traditional nutritional energy substrates.

## Dosage & Preparation

No clinically studied dosage ranges are specified for MicroActive CoQ10 Plus in the available research. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

CoQ10 is generally well tolerated at doses up to 1,200 mg/day; the most commonly reported side effects are mild gastrointestinal upset, nausea, and headache. CoQ10 may reduce the anticoagulant efficacy of warfarin (vitamin K antagonists) by sharing structural similarity with vitamin K, and patients on warfarin should consult a physician and monitor INR closely. PQQ at standard supplemental doses (10–20 mg/day) has shown no significant adverse effects in short-term human trials, though long-term safety data beyond 12 weeks are limited. MicroActive CoQ10 Plus has not been formally evaluated for safety in pregnancy or lactation, and its use is not recommended in these populations without medical supervision.

## Scientific Research

No specific human clinical trials, RCTs, or meta-analyses were found for MicroActive CoQ10 Plus or MicroActive CoQ10 in the research dossier. No PubMed PMIDs are available for this branded ingredient formulation.

## Historical & Cultural Context

No historical or traditional medicine context is provided for MicroActive CoQ10 Plus, as it is a modern patented ingredient with no documented traditional use.

## Synergistic Combinations

PQQ, Alpha Lipoic Acid, L-Carnitine, Magnesium, B-Complex Vitamins

## Frequently Asked Questions

### What is the difference between MicroActive CoQ10 and regular CoQ10?

MicroActive CoQ10 uses a cyclodextrin-complexed, sustained-release matrix designed to disperse CoQ10 in an amorphous form, releasing it gradually over ~24 hours to improve solubility and intestinal absorption. A small pharmacokinetic study (n=12) suggested approximately 3-fold greater bioavailability (AUC) compared to standard crystalline CoQ10 at equal doses. This may allow for lower effective doses, though independent replication in larger studies is still needed.

### What does PQQ do in MicroActive CoQ10 Plus?

PQQ (pyrroloquinoline quinone) at doses of 10–20 mg activates CREB, which upregulates PGC-1α and SIRT1 — master regulators of mitochondrial biogenesis that stimulate the creation of new mitochondria within cells. This complements CoQ10's role in optimizing existing mitochondrial function by potentially increasing the total number of mitochondria available for ATP production. Human trials with standalone PQQ at 20 mg/day have shown improvements in cognitive function scores and fatigue reduction over 12 weeks.

### How much MicroActive CoQ10 Plus should I take daily?

No standardized clinical dosing protocol exists specifically for MicroActive CoQ10 Plus as a combined product. General CoQ10 supplementation research uses doses of 100–300 mg/day for cardiovascular and energy support, while PQQ studies demonstrating cognitive and mitochondrial benefits typically use 10–20 mg/day. Consumers should follow the manufacturer's labeled dose and consult a healthcare provider to tailor dosing to individual health goals and concurrent medications.

### Can MicroActive CoQ10 Plus interact with heart or blood pressure medications?

CoQ10 has a documented interaction with warfarin, potentially diminishing its anticoagulant effect; patients taking warfarin should have INR monitored regularly if adding CoQ10 supplementation. Some evidence suggests CoQ10 may have a mild additive blood-pressure-lowering effect when combined with antihypertensive drugs, which could require dose adjustments. Individuals taking statins (HMG-CoA reductase inhibitors) often have depleted endogenous CoQ10 levels and may benefit from supplementation, but should inform their physician before starting.

### Is there clinical evidence that MicroActive CoQ10 Plus improves energy levels?

No published randomized controlled trials specifically examine the MicroActive CoQ10 Plus combination product for subjective energy or fatigue outcomes. Standalone PQQ at 20 mg/day was associated with statistically significant reductions in fatigue and improvements in sleep quality in a double-blind trial (n=41, 8 weeks). CoQ10 supplementation (300 mg/day) reduced fatigue in patients with fibromyalgia and mitochondrial disorders in separate trials, but evidence in healthy adults for energy enhancement remains inconsistent.

### Is MicroActive CoQ10 Plus safe to take during pregnancy and breastfeeding?

While CoQ10 is generally considered safe, there is limited safety data specifically for MicroActive CoQ10 Plus during pregnancy and breastfeeding. It is recommended to consult with a healthcare provider before use during these periods to determine if supplementation is appropriate for your individual situation. Pregnant or nursing women should not begin any new supplement regimen without professional medical guidance.

### Who would benefit most from taking MicroActive CoQ10 Plus?

MicroActive CoQ10 Plus may be beneficial for individuals over 40 (when natural CoQ10 levels decline), those taking statin medications that deplete CoQ10, and people seeking mitochondrial and cardiovascular support. The formulation may be particularly useful for those who prefer enhanced bioavailability over standard CoQ10 supplements. However, individual needs vary, and consultation with a healthcare provider can help determine if this supplement is appropriate for your health goals.

### How does the bioavailability of MicroActive CoQ10 Plus compare to ubiquinone and ubiquinol forms?

MicroActive CoQ10 Plus uses a proprietary formulation designed to enhance absorption compared to standard ubiquinone (oxidized CoQ10), though direct comparative bioavailability data with ubiquinol (reduced CoQ10) is not widely published. The enhanced delivery system aims to improve cellular uptake and utilization of the CoQ10. For optimal results, absorption may be improved when taken with a meal containing dietary fat, as CoQ10 is fat-soluble.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*